<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Significant advances in early <z:hpo ids='HP_0003002'>breast cancer</z:hpo> detection and increased quality of care within developed countries resulted in longer than five years survival in almost 90% of women diagnosed and treated for <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>One in twenty women diagnosed with <z:hpo ids='HP_0003002'>breast cancer</z:hpo> will develop a new primary non-breast <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> within 10 years from initial diagnosis </plain></SENT>
<SENT sid="2" pm="."><plain>Mutations in BRCA 1 i 2, RAD51C, MMR, p53, CDKN2A and 113insArg genes are linked with increased risk of <z:hpo ids='HP_0003002'>breast cancer</z:hpo> and other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> sites </plain></SENT>
<SENT sid="3" pm="."><plain>It seems that treatment modalities also play significant role in development of new primary <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Tissues that receive higher doses of radiation during radiotherapy of <z:hpo ids='HP_0003002'>breast cancer</z:hpo> are under increased risk of developing new <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e>, especially in younger women, ten years after the treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Chemotherapy may cause higher incidence of <z:hpo ids='HP_0001909'>leukemia</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> but lower overall risk for development of other <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Connection between <z:chebi fb="3" ids="41774">tamoxifen</z:chebi> therapy and increased risk of <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancer</z:e> is well known and confirmed also in recent studies </plain></SENT>
<SENT sid="7" pm="."><plain>The true mechanism of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development is still unclear </plain></SENT>
<SENT sid="8" pm="."><plain>Significance of hereditary factors, possible common environmental risk factors or unwanted side effects of the specific anticancer treatments are yet to be discovered </plain></SENT>
</text></document>